Definitive Healthcare Q4 Earnings Call Highlights
Definitive Healthcare (NASDAQ:DH) reported fourth-quarter 2025 results that management said landed at or above the high end of its guidance ranges, while outlining continued work to improve retention and rebuild a path to sustainable revenue growth. Q4 results and full-year performance Total revenue in the fourth quarter was $61.5 million, down 1% year-over-year, with adjusted [...]